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A B S T R A C T
This paper describes a formation of hybrid coatings on a Ti–2Ta–3Zr–36Nb surface. This is accomplished by
plasma electrolytic oxidation and a dip-coating technique with poly(adipic anhydride) ((C6H8O3)n) that is
loaded with drugs: amoxicillin (C16H19N3O5S), cefazolin (C14H14N8O4S3) or vancomycin (C66H75Cl2N9O24 ·
xHCl). The characteristic microstructure of the polymer was evaluated using scanning electron microscopy and
confocal microscopy. Depending on the surface treatment, the surface roughness varied (between 1.53 μm and
2.06 μm), and the wettability was change with the over of time. X-ray photoelectron spectroscopy analysis
showed that the oxide layer did not affect the polymer layer or loaded drugs. However, the drugs lose their
stability in a phosphate-buffered saline solution after 6.5 h of exposure, and its decrease was greater than 7%
(HPLC analysis). The stability, drug release and concentration of the drug loaded into the material were precisely
analyzed by high-performance liquid chromatography. The results correlated with the degradation of the
polymer in which the addition of drugs caused the percent of degraded polymer to be between 35.5% and 49.4%
after 1 h of material immersion, depending on the mass of the loaded drug and various biological responses that
were obtained. However, all of the coatings were cytocompatible with MG-63 osteoblast-like cells. The drug
concentrations released from the coatings were sufficient to inhibit adhesion of reference and clinical bacterial
strains (S. aureus). The coatings with amoxicillin showed the best results in the bacterial inhibition zone, whereas
coatings with cefazolin inhibited adhesion of the above bacteria on the surface.
1. Introduction
Implantology is a field of science that is constantly developing due
to an increasing number of biomaterials. Although a wide range of
biomaterials is known, titanium and titanium alloys have found wide-
spread use in implantology, for example, in orthodontic surgery.
Currently, a titanium Grade 4 and Ti–6Al–4V alloy is the most popular
biomaterial in orthopedic and orthodontic implant areas. Titanium
implants might be used for soft tissue and for hard, bone tissue, as well.
Due to their good mechanical properties, biocompatibility and corro-
sion resistance in simulated body fluid, titanium alloys are often used
compared to the Co–Cr or stainless steel implants [1–3]. Vanadium,
being a part of the Ti–6Al–4V alloy, is hazardous to human health due
to the toxicity of its corrosion products. A vanadium corrosion product,
such as V2O5, can lead to disorders of the cardiovascular system, heart
and kidneys, as well as Parkinson's disease [4]. Additionally, aluminum
compounds and aluminum ions have a negative effect on human or-
ganisms because their ions can be released and accumulated in the
brain, leading to diseases of the nervous system [5,6]. These problems
increase the intensity of research on vanadium-free and aluminum-free
titanium biomaterials. An innovative titanium alloy is a Ti–23Nb-
0.7Ta–2Zr-1.2 alloy, also known as Gum Metal, due to its low Young's
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modulus and specific plastic properties that cause it to be flexible [7].
This alloy is a promising material without aluminum and vanadium
compounds and shows good mechanical properties, such as high elas-
ticity, plasticity and strength, which are desirable for long-term bone
tissue implants. The Young's modulus of Gum Metal (~40 GPa) is also
lower than Ti–6Al–4V (~110 GPa), which results in better adjustment
to the Young's modulus of bone [8,9].
To obtain high biocompatible and cytocompatible properties of the
biomaterials, a surface modification of the titanium alloys might be an
easy solution. The plasma electrolytic oxidation (PEO) process is widely
used for the formation of functional coatings on titanium alloy surfaces.
During the PEO process, glow discharge and plasma occurs when the
oxide layer breaks down and the electric field accumulates near the
electrode surface and released gas [10]. Due to the anodization process,
a layer formed on the metal surface may increase its corrosion re-
sistance in simulated body fluid [11]. One of the important advantages
of the PEO process is that during anodizing, the elements and com-
pounds from the anodizing bath may be incorporated into the layer
[12]. For example, the incorporation of calcium and its compounds into
the TiO2 layer may support the adhesion of osteoblast cells, and their
proliferation provides for improved osseointegration processes [13].
Additionally, relatively simple voltage and current density control al-
lows the formation of oxide layers with controlled porosity [10].
After dental implantation, inflammation always occurs due to soft
and hard tissue damage. However, septic inflammation may occur
causing the loss of implants or promoting bone disease. Septic bone
disease, called osteomyelitis, is a dangerous illness that not only is
painful and problematic but also has long-term treatment which may
provide to remove the implant. The most common bacterial pathogens
causing osteomyelitis are Staphylococcus aureus, Staphylococcus epi-
dermidis, Pseudomonas aeruginosa and Escherichia coli [14–16]. As a
consequence of bone inflammation, bone and tissue necrosis and de-
struction appear. A detailed mechanism of osteomyelitis progress is
presented in the literature [17]. Due to these risks, patients need to be
treated with specifically selected antibacterial agents, which also in-
fluence other parts of the human or animal [18]. The most common
method of dosing antibiotics is the conventional oral route. A large dose
of antibiotics must be delivered once, and it can be up to 1.5 g per day,
using amoxicillin as an example [19]. There are some disadvantages for
using large doses of drugs, e.g., a large possibility of side effects and
allergic reactions and the necessity for taking frequent and high doses
of the drug. Metabolic drugs may sometimes accumulate in organisms,
and these drugs have been detected in high concentrations in the en-
vironment due to organism waste. The high concentrations of anti-
biotics and the periods of patient treatment by antibiotics also cause
several problems with antibiotic-resistant microbes, which are often
discussed worldwide. These troubles have resulted in the search for
new, safer and more convenient routes of drug delivery – implant drug
delivery system (IDDS) [20]. Incorporation of drugs into an implant can
resolve the above problems and initiate some improvements. To obtain
such an effect, biodegradable polymers can be used [21,22].
Thus far, biodegradable polymers such as poly(lactic-acid) (PLA),
poly(glycolic acid) (PGA), poly(ϵ-caprolactone) (PCL) and poly(lactide-
co-glycolide) (PLGA) are well known and widely used is used as bio-
materials in the field of bone tissue engineering [22–24]. The combi-
nation of titanium oxide layers obtained by the PEO process with bio-
degradable polymers allows the design of innovative hybrid oxide-
polymer coatings [25]. In drug delivery systems, biodegradable poly-
mers can be a matrix for releasing drugs. Depending on the polymer,
the drug release kinetics are different. In the case of applying biode-
gradable matrices, the drug can be delivered directly to an infected
place with a controlled time of release. Due to greater precision of the
drug delivery method, the necessary drug concentration is smaller, and
as a result, the number of side effects decrease [26]. Because antibiotics
have often been taken in high doses, bacteria in recent years have in-
creased their ability to withstand antibiotics. Using small doses of
drugs, e.g., IDDS, may slow down this process [27].
Among the biodegradable polymers, poly(adipic anhydride) (PADA)
seems to be an interesting choice for IDDS application. This polymer
distinguishes itself from others with its fast degradation ability (ap-
proximately 24 h depending on degradation conditions) [28,29]. Due to
its fast degradation (depending on pH, it is usually up to several hours)
and nontoxic hydrolysis products, PADA is considered a strong candi-
date for polymer matrices used in IDDS [30,31]. Additionally, there are
some difficulties related to the effectiveness of antibiotic incorporation
into an implant surface layer. Drugs are characterized by limited sta-
bility over time. Depending on the chemical surroundings of the anti-
biotics, they can degrade due to changes to their active chemical
structure becoming ineffective against bacteria. For this reason, having
a short for polymer matrix degradation and drug release time provides a
strong possibility of an observable antibacterial effect.
The aim of this work was to obtain hybrid layers consisting of ti-
tanium porous oxide and a PADA layer loaded with selected drugs such
as amoxicillin, cefazolin or vancomycin. The surface of a
Ti–2Ta–3Zr–36Nb alloy was anodized to form porous oxide layers at
high voltage. The polymeric part of the coating was formed using a dip-
coating method, and the appropriate conditions for forming functional
coatings were found. The surface morphology, surface roughness,
wettability, and chemical composition of the materials were analyzed
and discussed. The polymer layer and layer loaded with drugs were
analyzed using a confocal microscope. Drug concentrations released
from the coatings and drug stabilities were precisely analyzed and de-
termined by high-performance liquid chromatography. Antibacterial
properties were evaluated using reference and clinical Staphylococcus
aureus strains. Cytocompatibility was evaluated based on the metabolic
activity of the osteoblast-like cell line MG-63. Optimal parameters for
coating formation were found in order to obtain the best physico-
chemical properties of a material that would be desirable for dental
implants.
2. Materials and methods
2.1. Titanium alloy surface treatment
Samples of titanium alloy were cut from a metal rod
(Ti–2Ta–3Zr–36Nb, BIMO, Poland). The titanium alloy surfaces were
polished using SiC abrasive papers with granulation up to 1000. Then,
the pretreated titanium alloy samples were anodized in 0.1 M Ca
(H2PO2)2 solution at 300 V for 5 min. The current density during the
process was 150 mA∙cm−2. The plasma electrolytic oxidation (PEO)
process was carried out at 300 V and 150 mA∙cm−2 for 5 min. The
anodized samples were washed with deionized water and dried at room
temperature. The PEO process was performed in a cooled electrolyzer; a
Ti mesh was used as the cathode and the Ti alloys were used as the
anode to modify their surfaces.
2.2. Synthesis of poly(adipic anhydride)
Poly(adipic anhydride) (PADA) was synthesized from adipic acid by
a two-step acetylation and melt polycondensation method as reported
in the literature [32]. In the first step, prepolymer was obtained by
refluxing adipic acid in acetic anhydride (1:10 w/v) under a nitrogen
atmosphere for 0.5 h. Excess acetic anhydride and acetic acid formed in
this reaction as products and were removed with a rotary evaporator.
The prepolymer was formed by acetylation and in the second step was
condensed to yield PADA by heating at 150 °C for 2 h under high va-
cuum (0.1 mm Hg). The yield was approximately 70%. The obtained
polymer was stored in a freezer before being used in further experi-
ments without purification. The expected chemical structure of PADA
was confirmed by 1H NMR and 13C NMR.
PADA 1H NMR (CDCl3, ppm) δ: 2.40–2.60 (m, -CH2C(O)OC(O)-),
2.22 (s, CH3C(O)OC(O)-), 1.65–1.80 (m, -CH2CH2C(O)OC(O)-).
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PADA 13C NMR (CDCl3, ppm) δ: 168.84 (C]O), 34.69 (-CH2C(O)
OC(O)-), 23.26 (-CH2CH2C(O)OC(O)-). The average molecular weight
of PADA was calculated from an integration of the 1H NMR signals and
equaled 15 980.
2.3. Formation of the hybrid oxide-PADA layer
To form polymer layers on the anodized surface of the titanium
alloy (labeled GM), the sample was immersed in 1% (w/v) PADA so-
lution in CHCl3 (Sigma Aldrich, Poland) as a solvent. The samples were
immersed in this solution at a speed of 0.2 cm∙min−1. The time of
immersion in the PADA solution was 1 min for each one. Then, samples
were removed from the solution and dried at room temperature. PADA
layers loaded with drugs were prepared similarly, except that one of
three different antibiotics (amoxicillin or cefazolin or vancomycin) was
added to the polymer solution in an amount of 5 wt.% of the mass of
PADA. Table 1 presents the sample labels of the titanium alloys after the
surface treatment.
2.4. Surface analysis
The morphology of the PEO coatings and hybrid layers was in-
vestigated using a scanning electron microscope (Phenom Pro-X) with
voltages up to 5 kV. 3D SEM images were taken, and the roughness of
the surface was investigated by using software to determine the ar-
ithmetic roughness profile (Ra). The results are presented as an average
of 5 various lines analyzed for each sample. The surface wettability was
analyzed by measuring the water contact angle (goniometer
DataPhysics, OCA 15 EC, Germany). For this measurement, 0.2 μL of
deionized water was dropped on the investigated surfaces, and the
contact angle was measured over time. Three measurements from three
independent samples were collected and averaged.
The thickness of the oxide layer was determined using the same
scanning electron microscope (Phenom Pro-X). The sample was placed
into an epoxy-resin and ground using abrasive paper and diamond paste
according to the procedures presented in our previous paper [33]. For
the polymer layer morphology, a confocal microscopy analysis was
performed. The samples were immersed in a solution composed of Syto
9 dye (Thermo Fisher) and phosphate-buffered saline (PBS) solution for
15 min. Imaging was performed using an Olympus FV 1000 confocal
microscope with 40 × /NA 0.95 objectives. Z-stack images were gen-
erated using a 488-nm laser for FITC dye. 3D data sets were analyzed as
volume rendered data sets using Imaris (custom software developed by
Bitplane Scientific Software, Zurich, Switzerland).
2.5. Chemical composition of the hybrid layer
X-ray photoelectron spectroscopy (XPS) investigations were con-
ducted using a PREVAC EA15 hemispherical electron energy analyzer
with a 2D multichannel plate detector. The samples were irradiated an
energy of 1486.6 eV provided by an Al-Kα X-ray source (PREVAC dual-
anode XR-40B). The base pressure of the system was 5·10−9 Pa. The
following parameters were applied during spectra acquisition: for
survey spectra, 200 eV pass energy and a 0.9-eV scanning step and for
high-resolution spectra, 100 eV pass energy and a 0.05-eV scanning
step. All spectra were taken with a normal take-off angle. The energy
scale of the analyzer was calibrated to Au 4f7/2 (84.0 eV)25 and fitted
using CASA XPS® software. The Shirley function was used for back-
ground subtraction, while the components were represented by a pro-
duct of Gaussian (70%) and Lorentzian (30%) lines.
2.6. Polymer degradation
The degradation of PADA was investigated using 1H NMR spectro-
scopy (300 MHz spectrometer, UNITY-INOVA, Varian). A 2-ml solution
of 1% PADA and 5 wt% antibiotic (amoxicillin, cefazolin or vanco-
mycin) was prepared. As a solvent, artificial saliva (1.3 g∙dm−3
NaHCO3, 1.2 g∙dm−3 KCl, 0.7 g∙dm−3 NaCl, 0.33 g∙dm−3 KSCN,
0.26 g∙dm−3 Na2HPO4 and 0.13 g∙dm−3 urea; pH = 7.4) was used.
Prepared solutions were incubated at 37 °C with 60 rpm shaking. After
1 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 24 h and 48 h of degradation, the
solutions were frozen and lyophilized, dissolved in the mixture of
deuterated solvents CDCl3/DMSO (1:1 v/v) and analyzed via 1H NMR
spectroscopy.
2.7. Drug release and its stability
To determine the released drug concentration, an HPLC technique
(Merck-Hitachi chromatograph, pump L7100, DAD L-4500A) was used.
Fifteen samples, each with one hybrid layer, were immersed in 5 ml
artificial saliva and incubated at 37 °C. After 0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h
and 10 h, 200 μL of solution with the released drug was collected, and
then, the collected solutions were averaged with three independent
1 ml analysis samples. For amoxicillin and cefazolin analysis, an addi-
tional sample was collected after 5 h of hybrid layer degradation.
Before HPLC analysis, the solution was filtered (nylon filter, 0.22-μm
pore diameter). HPLC analysis was carried out using a TSK gel ODS-
100 V column, 150 mm × 4.6 mm with a particle size of 5 μm (TOSOH
BIOSCIENCE). The temperature during analysis was 22 °C. As a mobile
phase, 0.05% CF3COOH in water and acetonitrile solution (90:10 v/v)
was used. For cefazolin analysis, a mobile phase consisting of 0.05%
CF3COOH in water and acetonitrile solution (80:20 v/v) and a DAD
detector were used. For amoxicillin, the wavelength was set to 230 nm,
while for cefazolin the wavelength was 270 nm and for vancomycin, the
wavelength was 280 nm. The calibration curves for amoxicillin, cefa-
zolin and vancomycin determination in the artificial saliva matrix were
prepared via a procedure presented in our last work [34].
Studies on drug (amoxicillin, cefazolin, vancomycin) stability were
conducted at three different concentrations selected to represent the
range of concentrations in real samples and the linearity range of ca-
libration curves. Drug model solutions were prepared in PBS with
concentrations of 1 μg∙mL−1, 24 μg∙mL−1 and 50 μg∙mL−1. Three par-
allel samples of a given concentration were prepared, and each sample
was injected thrice. An analysis was performed immediately after pre-
paration of the solution (time zero) and then after 6.5, 13, 22 and 29 h
for amoxicillin; 7, 14, 21 and 28 h for cefazolin; and 6.5, 13 and 21 h for
vancomycin. All samples were stored at room temperature. The selected
time point differences for each drug were due to the different times
required for chromatographic analysis of each drug.
2.8. Antimicrobial properties investigations
The microbial tests were carried out using reference Staphylococcus
aureus ATCC 25923 and clinical Staphylococcus aureus MRSA 1030
bacterial strains. Before testing, the bacteria were cultured in a Tryptic
Soy Broth (TSB) culture medium (Biocorp, Poland) at 37 °C for 18 h
(incubator ES-20/60, Biosan). First, the inhibition zones of bacteria
were determined. The bacteria (~106 CFU∙mL−1) were spread onto
agar plates (Muller-Hinton agar, Diag-Med Poland). Then, a 5-mm hole
Table 1
Sample labels of the titanium alloy surfaces.
sample label PEO dip-coating
in 1% PADA
solution
antibiotic in hybrid layer
amoxicillin cefazolin vancomycin
GM × × × × ×
GM-PEO ✓ × × × ×
GM-PADA ✓ ✓ × × ×
GM-PADA_AMX ✓ ✓ ✓ × ×
GM-PADA_CEF ✓ ✓ × ✓ ×
GM-PADA_VANCO ✓ ✓ × × ✓
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was cut out from the middle of the agar plate. Next, 100 μL of sample
solution (collected after hybrid layer degradation) was placed into this
hole. Agar plates were incubated at 37 °C for 24 h, after which, the
inhibition zones were measured.
2.9. Bacterial adhesion
Bacterial adhesion tests were carried out using two different bac-
terial strains: reference Staphylococcus aureus (ATCC 25923) and clin-
ical Staphylococcus aureus (MRSA 1030). Before testing, the bacteria
inoculate was incubated for 18 h at 37 °C in 50 cm3 of BactoTM Tryptic
Soy Broth (TSB) (Becton Dickinson). Then, the investigated samples
were placed into 24-well plates. On their surfaces, 1 mL of bacterial
suspension (~1∙108 CFU∙mL−1) was added, and the samples were in-
cubated at 37 °C for 4 h with shaking at 60 rpm. Then, the samples were
gently washed with PBS solution (8.0 g∙L−1 NaCl, 0.2 g∙L−1 KCl,
1.44 g∙L−1 Na2HPO4, 0.24 g∙L−1 KH2PO4). To remove the adhered
bacteria, the samples were placed into new 24-well plates and treated
intensively with 1 mL of 0.25% trypsin. Then, 100 μL of the bacteria
and trypsin solution were collected and mixed with 0.9% NaCl at
concentrations of 1:1000, 1:10 000, and 1:100 000. One hundred mi-
croliters of the prepared solutions were spread on agar plates. The agar
plates were incubated at 37 °C for 24 h. After that, the bacterial colonies
were counted.
2.10. Cytocompatibility
To determine the cytocompatibility of the Gum Metal surfaces, MG-
63 osteoblast-like cells were used for testing. The investigated sample
surfaces without polymer layers were sterilized in steam at 134 °C and
under 2.1 bar pressure (Bravo 21V, SiCan). The PADA and drug-loaded
PADA surfaces were sterilized using a laminar equipped with a UV lamp
for 30 min. Sterilized samples were placed into 24-well plates. On the
surfaces, MG-63 osteoblast-like cells were seeded. The cell density in
the suspension was 8000 cells per sample. The samples were incubated
at 37 °C for 7 days under a 5% CO2 atmosphere. After 24 h, 3 days and 7
days, 100 μL of Alamar Blue (In Vitro Toxicology Assay Kit, Resazurin
based, Sigma-Aldrich) was added to the surface of each sample. The
samples were incubated at 37 °C for 4 h. Then, 100 μL of solution from
each well was collected and placed into a new, 96-well plate. The ab-
sorption of collected solutions was measured with a FLUOstar Omega
microplate reader (BMG Labtech) and a “live/dead” test was carried
out. The investigated material was incubated with 2 μL of propidium
iodide (1 mg∙mL−1) and AM calcein (1 mg∙mL−1) for 30 min. The
surface morphologies were determined using a Zeiss Axiovert 40 (Carl
Zeiss, Germany) optical microscope. The live cells are visible as green,
and the dead are red.
3. Results
3.1. Surface characterization of hybrid layers
The 2D and 3D SEM images of the investigated surfaces are pre-
sented in Fig. 1. Pores visible on images are the result of the PEO
process. The average roughness coefficient (Ra) value of the untreated
GM surface was 0.61 μm ± 0.02. After PEO treatment, the Ra of the
anodized GM surface increased to 1.24 μm ± 0.35 for the GM-PEO
surface. Formation of the polymer (PADA) layer on the previously an-
odized GM alloy caused that Ra slightly increased up to 1.29 μm ±
0.05. However, the morphology and the surface roughness value were
not significant different compared with the only anodized sample. 2D
and 3D SEM images of the GM-PADA sample are presented in supple-
mentary materials. The significant differences were detected where the
confocal microscopy was applied. The Ra values of GM surfaces with
hybrid layers containing antibiotics were measured with values of
1.53 μm ± 0.26 for GM-PADA_AMX, 1.92 μm ± 0.28 for GM-
PADA_VANCO, and 2.06 ± 0.36 μm for GM-PADA_CEF, which was the
highest observed value.
Anodization of the GM surfaces caused an oxide layer to form with
open and closed pores. Thus, there was variation in the layer thickness
and the cracks that might be formed in the layer due to spark dis-
charges. Fig. 2A presents the cross-section of the GM-PEO layer ob-
served using the SEM microscope. The thickness of the formed oxide
layer was between 8.54 μm and 11.20 μm. Fig. 2B–E presents 3D images
of the polymer layer with and without drugs. The thickness of the
polymer layer was determined using a confocal microscope after im-
mersing the samples in a solution with SYTO 9 dye. The layers cannot
be observed using the SEM microscope. For the GM-PEO-PADA, the
determined layer thickness was 13.77 μm, for the GM-PADA_AMX, it
was 10.22 μm, for the GM-PADA_CEF, it was 9.87 μm, and for the GM-
PADA_VANCO, it was 10.34 μm.
Fig. 3 presents the dynamic contact angle changes of the in-
vestigated GM surfaces as a function of time. The contact angle of all
investigated surfaces was less than 90°, so it can be concluded that all
investigated samples are hydrophilic. The most hydrophilic surface was
observed for the GM-PADA_VANCO surface. Its contact angle measured
39.51° at the maximum point, and the total time of water drop
spreading was 69 s. Similar tendency was observed for the sample
without drug: GM-PADA. In comparison, the GM-PADA_AMX and GM-
PADA_CEF were also characterized by low contact angle, indicates
hydrophilic surfaces. The contact angle determined for the GM-PA-
DA_AMX was 63.02°, and for the GM-PADA_CEF, it was 51.24°, while
their water drop spreading times were less than 100 s. The measure-
ments were stopped, where the surfaces became highly hydrophilic and
the contact angle could not be determined.
3.2. Chemical composition of the hybrid layers
The chemical structures of the resulting inorganic and organic
layers were confirmed by XPS.
The survey spectra recorded for all materials are presented in Fig. 4.
For all the samples, signals coming from alloys covered with an oxide
layer, i.e., O 1s, Ti 2p, Nb 3d and Ta 4f, and from species coming from
the electrooxidation medium, i.e., Ca 2p and P 2p can be observed at
approximately 530, 459, 210, 26, 347 and 134 eV, respectively.
In the next step, high-resolution spectra were recorded for PEO,
giving more details about the chemical structure of the oxide layer. As
shown in Fig. 5a, in the case of Ti 2p, one component, Ti 2p3/2, with its
spin-orbit splitting counterpart is observed at 457.2 eV, indicating that
Ti2O3 oxide was formed. Similarly, the regions for the Nb 3d and Ta 4f
(Fig. 5b and c) reveal one component together with a spin-orbit split-
ting addition, Nb3d5/2 at 207.5 eV and Ta4f7/2 at 25.8 eV, suggesting
the presence of metal oxides at the highest oxidation state, i.e., N2O5
and Ta2O5. Importantly, no additional signals arising from unoxidized
metals are observed, which confirms the integrity and continuity of the
oxide layer. Next, as shown in Fig. 6a, the representative position of the
Ti 2p signal recorded for the GM-PEO surface covered with the poly-
meric layer remained unchanged, which proves that no covalent
linkage is formed between the PADA and alloy oxides. As already
mentioned, both phosphorus and calcium are introduced into the oxide
layer during the electrochemical oxidation process. The high-resolution
XPS spectrum of the P 2p region reveals two close spin-orbit compo-
nents, P 2p3/2 and P 2p1/2, at 133.8 and 134.7 eV, respectively, which
are typical for metal phosphates. Finally, the decomposition of the C 1s
high-resolution spectrum recorded for the bare inorganic layer reveals
three signals with maxima at 284.5, 286.7 and 288.7 eV that can be
assigned to C–C, C–O and C]O, respectively, from the adventitious
carbon layer. The same components are present in the C 1s region of
GM-PADA, although the relative intensity of the C–O and C]O com-
ponents is significantly higher when compared to the C–C component,
which confirms the presence of a deposited polymeric layer (see Fig. 7).
Further modification of PADA by the introduction of antibiotics into
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the polymeric matrix results in the appearance of additional N 1s sig-
nals at approximately 400 eV and S 2p signals at approximately 168 eV
in the recorded survey spectra (Fig. 4) for GM-PADA_AMX and GM-
PADA_CEF, and S 2p at approximately 168 eV for GM-PADA_VANCO.
The high-resolution spectrum of S 2p (Fig. 6) acquired for GM-PA-
DA_AMX shows two spin-orbit components with S 2p3/2 located at
166.0 eV, which can be assigned to the C–S bond. These results confirm
that the active agents were successfully incorporated into the PADA
polymer matrix.
3.3. PADA degradation
Table 2 presents the degradation of the polymer (PADA) and
polymer with amoxicillin, cefazolin or vancomycin in various periods of
time: 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 24 h and 48 h.
Degradation progress is presented as the content of adipic acid
groups, calculated as ratio of acid groups to sum of acid and anhydride
groups. The hydrolysis percentage of the PADA polymer and the
polymer with the drugs after 1 h of degradation is in the range from
35.5% for PADA_AMX to 49.4% for PADA_CEF. The results of 1H NMR
analysis of PADA hydrolysis progress indicate that the PADA polymer
quickly degrades because over 50% of its initial mass is degraded after
less than 12 h. In addition, based on the obtained results, it is worth
noting that the degradation process depends on the kind of drug loaded
into the polymer layer as degradation proceeded over 80% after 24 h.
The PADA_AMX hybrid layer has the maximum hydrolysis percentage
of 90.1% after 48 h.
3.4. Drug release concentration
Fig. 8 presents the results of the drug concentration after various
exposure times of the drug in PBS solution.
The concentrations of amoxicillin, cefazolin and vancomycin were
determined by HPLC after 6.5 h, 13 h, 20 h and 27 h of drug exposure in
the vials. The concentrations of all the drugs significantly influenced
their stability in PBS solution to optimize time for drug release from the
hybrid coatings. After 6.5 h, prepared solutions with drug concentra-
tions of 1 μg∙mL−1 showed a decrease in stability by approximately 8%.
The drugs showed much better stability in PBS solution when the drug
concentrations were 25 μg∙mL−1 or 50 μg∙mL−1. Vancomycin at a
concentration of 1 μg∙mL−1 was less stable in the PBS solution com-
pared with the results determined for amoxicillin and cefazolin. When
the concentration of drug in the PBS solution was 25 μg∙mL−1, vanco-
mycin showed better stability, whereas the stability of amoxicillin
Fig. 1. 2D and 3D SEM images of the GM-PEO (A,B), GM-PADA_AMX (C,D), GM-PADA_CEF (E,F) and GM-PADA_VANCO (G,H) samples.
Fig. 2. SEM image of the cross-section for the GM-PEO sample (A) and the 3D
images determined for the GM-PEO-PADA (B), GM-PADA_AMX (C), GM-
PADA_CEF (D) and GM-PADA_VANCO (E) samples. The thickness of the ano-
dized layer is between 8.54 and 11.20 μm. The thickness measurements of the
polymer layers formed on the previously anodized surface of the titanium alloys
are shown in the corner (yellow number). The addition of drugs influenced the
polymer layer thickness, which significantly changed its biological activity.
Fig. 3. Contact angle changes of the investigated surfaces as a function of time.
The morphologies of the surfaces also significantly influenced the surface
wettability and contact angle between the material and drop of water.
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significantly decreased. This tendency was also observed when the
concentration of the drugs increased to 50 μg∙mL−1. For all drugs, their
primary content in the PBS solution decreased after only 6.5 h of sample
preparation. This meant that the drug concentration released from the
coatings were determined with the error tolerance, which occurred due
to the various stability of the drugs in the PBS solution. High drug
concentrations in the PBS solution caused their stability to be much
better, and the drugs were not adsorbed on the vial walls. Drug de-
gradation products were not observed on all chromatograms. Based on
these results, the drug concentrations released from the hybrid coatings
was determined for up to 10 h after material immersion. This length of
time is also the most important for preventing bacterial adhesion and
biofilm formation.
Fig. 9 presents the results of the released drug concentration de-
pending on the hybrid layer degradation time. For the GM-PADA_AMX
sample after 0.5 h of hybrid layer degradation, the released amoxicillin
concentration was 1.80 μg∙mL−1. Then, after 1 h of degradation, the
drug concentration increased to 1.90 μg∙mL−1 and after 2 h to
1.94 μg∙mL−1. Afterward, the concentration started to slightly decrease
and was 1.51 μg∙mL−1 after 4 h, 1.46 μg∙mL−1 after 5 h, 1.48 μg∙mL−1
after 6 h, 1.40 μg∙mL−1 after 8 h and 1.38 μg∙mL−1 after 10 h.
Contrary to the amoxicillin release from the GM-PADA_AMX
Fig. 4. XPS survey spectra recorded for the GM-PEO, GM-PADA, GM-PADA_AMX, GM-PADA_CEF and GM-PADA_VANCO samples.
Fig. 5. High-resolution XPS spectra recorded for the GM-PEO sample: a) Ti 2p, b) Nb 3d, c) Ta 4f, d) P 2p and e) C 1s.
Fig. 6. High-resolution XPS spectra recorded for the GM-PADA sample: a) Ti 2p
and b) C 1s.
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surface, the drug release concentration profile of cefazolin and vanco-
mycin increased over time. The released cefazolin concentration started
with 1.02 μg∙mL−1 after 0.5 h and increased. It was 1.09 μg∙mL−1 after
1 h, 1.15 μg∙mL−1 after 2 h, 1.18 μg∙mL−1 after 4 h and stayed the same
after 5 h. The concentration was then 1.26 μg∙mL−1 after 6 h,
1.33 μg∙mL−1 after 8 h and 1.34 μg∙mL−1 after 10 h.
Vancomycin was released with the highest concentrations. After
0.5, the released vancomycin concentration was 5.10 μg∙mL−1. Then,
the concentration was 5.48 μg∙mL−1 after 1 h, 5.63 μg∙mL−1 after 2 h,
5.43 μg∙mL−1 after 4 h, 5.50 μg∙mL−1 after 5 h, 5.78 μg∙mL−1 after 8 h
and 6.06 μg∙mL−1 after 10 h.
3.5. Bacterial growth inhibition zones
Table 3 presents Staphylococcus aureus growth inhibition zones. For
GM-PADA_AMX, the inhibition zone was measured and was 18 mm for
an S. aureus clinical strain MRSA 1030, while it was larger, 30 mm, for
the reference strain ATCC 25923. A different tendency was observed for
GM-PADA_CEF and GM-PADA_VANCO, where growth inhibition zones
of the reference S. aureus (ATCC 25923) were smaller than the clinical
MRSA 1030 zones. The measurement values for GM-PADA_CEF were
24 mm (MRSA 1030) and 15 mm (ATCC 25923), and the measurement
values for GM-PADA_VANCO were 16 mm (MRSA 1030) and 12 mm
(ATCC 25923).
Fig. 7. High-resolution XPS spectra of the S 2p region recorded for the GM-
PADA_AMX sample.
Table 2
Degradation of the polymer (PADA) and polymer with drugs: amoxicillin, cefazolin or vancomycin up to 48 h.
sample labels calculated parameters degradation time, h
1 2 4 6 8 10 12 24 48
PADA anhydride groups/acid groups ratio [mol/mol] 1:0.31 1:0.47 1:0.88 1:1.08 1:1.68 1:1.74 1:1.59 1:3.57 1:7.29
content of adipic acid [%] 23.9 32.1 46.9 51.9 62.77 63.6 61.4 78.1 87.5
PADA_AMX anhydride groups/acid groups ratio [mol/mol] 1:0.55 1:0.74 1:1.23 1:1.77 1:1.62 1:1.52 1:1.62 1:4.22 1:9.08
content of adipic acid [%] 35.5 42.4 55.2 63.9 61.8 60.2 61.8 80.8 90.1
PADA_CEF anhydride groups/acid groups ratio [mol/mol] 1:0.97 1:1.19 1:2.00 1:2.12 1:1.95 1:2.28 1:2.13 1:6.28 1:7.92
content of adipic acid [%] 49.4 54.4 66.7 67.9 66.1 69.6 68.0 86.3 88.8
PADA_VANCO anhydride groups/acid groups ratio [mol/mol] 1:0.92 1:1.49 1:1.90 1:2.20 1:1.39 1:1.28 1:1.88 1:4.01 1:5.33
content of adipic acid [%] 47.8 59.9 65.5 68.7 58.2 56.1 65.3 80.0 84.2
Fig. 8. Concentration of amoxicillin (A), cefazolin (B) and vancomycin (C) after
different exposure times in PBS solution.
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3.6. Bacterial adhesion tests
The bacterial adhesion results are presented in Fig. 10. After com-
paring surfaces loaded with drugs to those without drugs, all drug-
containing surfaces show a visible decrease in the amount of adhered
bacteria. For the GM, GM-PEO and GM-PADA surfaces, the minimal
observed adhered bacteria amount was 2.6·106 CFU∙mL−1 (GM-PADA,
ATCC 25923), and the maximal amount was 1.5·108 CFU∙mL−1 (GM-
PADA, MRSA 1030). Surfaces loaded with drug exhibited stronger
bacteriostatic effects than those without antibiotics. The minimal
amount of adhered bacteria was observed for the GM-PADA_CEF hybrid
layer, which was equal to 1.5·105 CFU∙mL−1 for the ATCC 25923 strain
and 3.0·105 CFU∙mL−1 for the MRSA 1030 strain. For the GM-PA-
DA_AMX and GM-PADA_VANCO surfaces, the amount of S. aureus, in
any case, was no higher than 4.1·106 CFU∙mL−1 (GM-PADA_VANCO,
ATCC 25923). It is worth noting that GM-PADA_CEF and GM-PADA_-
VANCO exhibited stronger antibacterial effects on the clinical strain
(MRSA 1030) than on the reference strain (ATCC 25923). The amount
of adhered bacteria was 2.3–4.8·109 CFU∙mL−1 for the control mea-
surement, and thus, all investigated samples revealed less favorable
conditions for bacterial adhesion than the control.
3.7. Cytocompatibility
Fig. 11 presents the Alamar Blue percent reduction, which corre-
sponds to the viability of MG-63 osteoblast-like cells on the investigated
surfaces after incubation (24 h, 3 days and 7 days). The GM surface
(unmodified Ti alloy surface) after the PEO treatment exhibited better
cytocompatibility (GM-PEO sample). This can be related to the increase
in roughness after the PEO process, but also the chemical composition
of the oxide layer. The viability of the MG-63 cells on the hybrid layers
was slightly higher than on the GM-PEO surface. After 7 days of in-
cubation. 21.97% of Alamar Blue reduction was observed on the GM-
PADA_AMX surface, while a similar result was observed for the GM-
PADA_VANCO surface with a total of 21.58%. The GM-PADA_CEF
surface exhibited a slightly lower Alamar Blue reduction percent than
the above and was 18.46% after 7 days of incubation.
Fig. 12 presents images of the MG-63 cell cultures on the in-
vestigated surfaces. MG-63 cells on the GM surface were not well at-
tached to the surface. The number of cells was rather small, and their
Fig. 9. Release concentrations of amoxicillin, cefazolin and vancomycin after
hybrid layer degradation of up to 10 h.
Table 3
Clinical Staphylococcus aureus (MRSA 1030) and reference Staphylococcus aureus
(ATCC 25923) growth inhibition zones.
sample bacterial growth inhibition zone, mm
S. aureus (ATCC 25923) S. aureus (MRSA 1030)
GMa 5 5
GM-PEOa 5 5
GM-PADAa 5 5
GM-PADA_AMX 30 18
GM-PADA_CEF 15 24
GM_PADA_VANCO 12 16
a Values of 5 mm indicate the collected solutions from the investigated places
showed no inhibition zones.
Fig. 10. Adhesion tests of S. aureus (ATCC 25923 and MRSA 1030) on in-
vestigated surfaces of GM, GM-PEO, GM-PADA, GM-PADA_AMX, GM-
PADA_CEF and GM-PADA_VANCO.
Fig. 11. Viability of MG-63 osteoblast-like cells after 24 h, 3 days and 7 days of
incubation. The results are presented as the mean ± SD. Statistically sig-
nificant differences between the samples and the control (TCPS) are indicated
by * (*<0.05, **p < 0.01, ***p < 0.001).
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shape was triangular, which indicated a lack of cellular preference for
proliferation on the GM surface. A completely different situation could
be observed for the GM-PADA surface after PEO treatment and after
polymer layer deposition. In this case, after 24 h, cells attached quite
well on the surface, which could be observed due to their flatter shape
and the increased number of cells. Comparing the GM-PADA surfaces
with additions of amoxicillin, cefazolin or vancomycin, it could be seen
that after 24 h of cell culture, the best results were obtained for the GM-
PADA_VANCO surface, where the cells preferred adhesion and pro-
liferation. The best results were observed for the 7-day MG-63 cell
culture on the GM-PADA_AMX surface. Cells proliferated in the highest
amount in comparison to other drug-loaded surfaces. For GM-PA-
DA_CEF and GM-PADA_VANCO, the shape and amount of MG-63 cells
was also evidence of good adhesion and proliferation of living cell
conditions. All these results were also confirmed by cytocompatibility
tests using the Alamar Blue reduction percentage.
4. Discussion
Among all biomaterials, titanium and its alloys seem to be favored
for use as long-term implantable materials. This is not only due to the
good mechanical and biocompatible properties or corrosion resistance
of titanium but also the possibility of relatively simple surface treat-
ment applications. Anodization of Ti alloy surfaces where spark
discharges occur results in high porosity, increasing surface roughness
and changing wettability, which are considered to be very important
features for the integration of implant material with bone tissue.
Additionally, adjusting the PEO parameters, such as applied voltage,
current density or anodizing bath composition, provides an opportunity
to create a variety of functional biomaterials with different surface
characteristics. It has been reported that it is possible to anodize real-
shape implants with a chemical composition suitable for their os-
seointegration process. The formation of hybrid coatings on real-shape
implants is also possible. The dip-coating method is widely used,
making it possible to cover the metal surface of complicated shapes.
This advantage is technologically important for the successful surface
treatment of Ti-based implants available on the market.
In this work, the results of the PEO treatment of the titanium alloy
Ti–2Ta–3Zr–36Nb (GM sample) surface indicate that the wettability
and surface roughness of the investigated samples increased. A slight
increase in hydrophobicity was observed when comparing the contact
angles of different GM-PADA surfaces to the GM-PEO surface, which
can be explained by the hydrophobic structure of antibiotics loaded into
the polymer layer or also changes of the surface roughness which sig-
nificant influences on a wettability. However, every type of investigated
surface revealed a contact angle of less than 90°, which confirms the
hydrophilic character of the investigated materials. Additionally, the
value of the arithmetic roughness coefficient increased after PEO and
Fig. 12. MG-63 cell culture images after 24 h, 3 days and 7 days with the GM, GM-PADA, GM-PADA_AMX, GM-PADA_CEF and GM-PADA_VANCO surfaces and TCPS
as a reference.
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was 1.53 μm–2.06 μm. Similar implant surface roughness and bone
tissue can support osseointegration and long-term implant use. The
required Ra value of implant-intended biomaterials should be ap-
proximately 2 μm [35].
The XPS surveys confirmed the presence of Ti2O3 in the oxide layer
without breaking the continuity of the formed oxide layer. The in-
corporation of Calcium and phosphorus was also detected and verified.
These elements are simultaneous bone building components, so their
successful incorporation into the oxide layer increases its bioactivity.
Polymer layer associations with the PEO layer were not observed via
XPS analysis, which indicates that the degradation of the PADA layer
can easily proceed in a human body fluid environment, enabling a
controlled release of drugs. All these results prove PEO to be a good
choice as a surface modification process because of the possibility of
obtaining biomaterials with more biocompatible physicochemical
properties when compared to bone tissue.
Septic bone inflammation is a common difficulty related to im-
plantation processes. The main pathogen leading to this disease is the
group of bacteria named Staphylococcus [36]. This kind of infection is
very difficult to treat due to the ability of bacteria to create biofilms
that are particularly resistant to different antibacterial agents [37].
According to MIC values presented in the available database EUCAST,
the MIC of amoxicillin, cefazolin and vancomycin against Staphylo-
coccus aureus and Staphylococcus epidermidis is in the range of
0.12 μg∙cm−3 to 2.00 μg∙cm−3. The results presented in this paper in-
dicate a similar order of magnitude of bacteriostatic efficient con-
centrations of amoxicillin, cefazolin and vancomycin released from the
hybrid layers. After 0.5 h of release, amoxicillin was released at a
concentration of 1.8 μg∙cm−3, cefazolin 1.02 μg∙cm−3, and for vanco-
mycin was 5.10 μg∙cm−3. Additionally, the bacterial growth inhibition
zone measured for the solution containing antibiotics released from the
hybrid layer after 0.5 h was in the range from 12 to 30 mm against S.
aureus (ATCC 25923) and 16–24 against S. aureus (MRSA 1030). These
results demonstrate the bacteriostatic effect of antibiotics containing
PADA layers formed on GM surfaces against Staphylococcus bacteria
after 0.5 h of release. The period of time immediately after the im-
plantation process is especially important because of the treated tissues
have an increased susceptibility to bacterial attack during surgery. The
antibiotic release concentration did not change significantly after 10 h
of hybrid layer degradation, revealing an undiminished release of an-
tibiotic concentrations after 10 h.
The antibiotic stability was also determined. The results show that
the stability of the investigated drugs was dependent on the initial drug
concentration. Starting with drug concentrations equal to 25 μg∙cm−3
or 50 μg∙cm−3, the drug stability did not decrease below 87.6%
(amoxicillin, 27 h). However, no degradation products of antibiotics
were observed during HPLC, which suggests undiminished effectiveness
of the drug released from the hybrid layer. Additionally, 1H NMR stu-
dies show that PADA can be considered as a easily hydrolyzable
polymer due to a higher than 85% of hydrolytic degradation. In con-
clusion, fast degradation of PADA can ensure sufficient antibiotic sta-
bility and, consequently, good antibacterial effectiveness of the formed
hybrid layers.
All three investigated surfaces loaded with drugs (GM-PADA_AMX,
GM-PADA_CEF and GM-PADA_VANCO) exhibited good cytocompat-
ibility. According to tests with MG-63 osteoblast-like cells, there is a
visible increase in cell proliferation after 7 days on every type of anti-
biotic-containing hybrid layer. Additionally, the images confirm good
living cell proliferation conditions on the investigated surfaces. It is
possible to observe that after 7 days of cell incubation, their amount
and rather flat shape demonstrate good cytocompatibility with the in-
vestigated surfaces. Comparing these results to bacterial adhesion tests,
it is worth noting that the PADA hybrid layers containing amoxicillin,
cefazolin or vancomycin provide an opportunity to design biomaterials
with good antibacterial and cytocompatible properties.
The coatings composed of cefazolin and vancomycin exhibited good
cytocompatibillity, however the surface with cefazolin showed better
properties against adhesion of the bacteria. These result is correlated
with the drug concentration loaded into the polymer layer, where the
concentration of cefazolin was higher than vancomycin. On the other
hand, the molecular weight of vancomycin is much higher than for
cefazolin, and the diffusion rate of drug into the solution could be
significant different. Thus, the better activity against bacteria was ob-
served for the sample with cefazolin, but concentration of drug loaded
in both coatings (cefazolin and vancomycin) was not toxic for the MG-
63 osteoblast cells. Fast degradation of PADA and, as a consequence, its
fast antibiotic release can enable quick drug delivery directly to in-
fected places, which claims to be a highly important feature of bio-
materials designed as implants. It is also worth noting that bacterial
growth inhibition zones for the GM-PADA_AMX of the clinical strain of
Staphylococcus aureus (MRSA 1030) are significantly lower than in the
case of the reference strain (ATCC 25923). Thus, the stronger anti-
bacterial effect against the clinical S. aureus strain than against the
reference strain can be concluded for the GM-PADA_AMX hybrid layer.
It is also very beneficial because the clinical strains (for example, MRSA
1030) are generally more resistant to antibiotic action than the re-
ference strains (ATCC 25923).
The coating formed by plasma electrolytic oxidation process,
usually shows good adhesion to the substrate. It was reported, that the
ceramic coating like TiO2 formed on the Ti alloys during the anodiza-
tion process, might be not brittle and not cracks during the scratch test
measurements [38]. However, it should be point that the final effect
depends on the anodization conditions and the structure of the formed
coating. It was reported, that microstructure of the substrate strongly
influences on the adhesion between a metal substrate and polymer layer
[39]. In this case, the substrate is recognized as the anodized titanium
alloy, which structure is favorable to attach polymer layer loaded with
drug. It indicates, that the adhesion of the polymer on the top of the
oxides could be satisfying. XPS analysis confirmed that there are no
chemical connections between the polymer and the oxides, however the
aim of this work is fast degradation of the polymer, so in this case is an
advantage.
Titanium alloys called as gum metals, in this case
Ti–2Ta–3Zr–36Nb, exhibit mechanical properties close to the natural
bone. This is a promising material in implantology, due to the bio-
compatibility, excellent mechanical properties and possibility to make a
real shape implants such as dental implants. However, price of the gum
metals is relatively high at the moment, and the formation of the
functional implant is expensive. On the other hand, this paper shows
that the surface of this titanium alloys might be provided in easy way,
and the results are promising to evaluate these implants (especially
with amoxicillin) in in vivo experiments, according to the ISO 10993
standard.
5. Conclusions
In this paper, a poly(adipic anhydride) layer loaded with antibiotics
was deposited on the surface of a Ti alloy, Ti–2Ta–3Zr–36Nb (type of
Gum Metal), which was first treated using a plasma electrolytic oxi-
dation process. The surface morphology, surface roughness and wett-
ability for each of the obtained anodized surfaces were investigated. It
was concluded that PEO surfaces were porous with an observable in-
crease in surface roughness and wettability and demonstrated no ob-
servable defects or cracks. Next, for the Ti alloy oxide layer, the poly
(adipic anhydride) containing one of three different drugs, amoxicillin,
cefazolin or vancomycin, was deposited via a dip-coating method. The
surface microstructure of the polymer was analyzed using a confocal
microscope and indicated the specific microstructure, which was fa-
vorable for the adhesion and proliferation of MG-63 osteoblast-like cells
MG-63. The obtained hybrid layer degradation time was measured up
to 48 h, and poly(adipic anhydride) was concluded as a relatively fast-
degrading polymer, achieving a hydrolysis progress of over 80% after
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48 h of degradation. Furthermore, the XPS studies indicated that the
poly(adipic anhydride) polymer was not associated with the Ti alloy
oxide layer, allowing fast polymer degradation and drug release. The
antibiotic release concentrations were measured up to 10 h, main-
taining drug concentrations sufficient for inhibiting bacterial growth.
The antibacterial effect of hybrid coatings was confirmed by tests with
two bacterial strains: Staphylococcus aureus ATCC 25923 and
Staphylococcus aureus MRSA 1030. Satisfactory results from the cyto-
compatibility studies using MG-63 osteoblast-like cells were also ob-
tained. A good proliferation of living cells was determined on the in-
vestigated surfaces, even after the addition of antibiotics. The stability
of released antibiotics was determined for up to 27 h, and after 6.5 h,
the stability of the three drugs significantly decreased. These findings
indicate that the evaluation of the drug release from the materials could
not determine if 100% of the loaded drugs were effectively released.
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